141 related articles for article (PubMed ID: 37789148)
1. Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients.
Jahn E; Saadati M; Fenaux P; Gobbi M; Roboz GJ; Bullinger L; Lutsik P; Riedel A; Plass C; Jahn N; Walter C; Holzmann K; Hao Y; Naim S; Schreck N; Krzykalla J; Benner A; Keer HN; Azab M; Döhner K; Döhner H
Leukemia; 2023 Nov; 37(11):2336-2337. PubMed ID: 37789148
[No Abstract] [Full Text] [Related]
2. Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older.
Prassek VV; Rothenberg-Thurley M; Sauerland MC; Herold T; Janke H; Ksienzyk B; Konstandin NP; Goerlich D; Krug U; Faldum A; Berdel WE; Wörmann B; Braess J; Schneider S; Subklewe M; Bohlander SK; Hiddemann W; Spiekermann K; Metzeler KH
Haematologica; 2018 Nov; 103(11):1853-1861. PubMed ID: 29903761
[TBL] [Abstract][Full Text] [Related]
3. Development of a NanoString assay to detect leukemogenic fusion transcripts in acute myeloid leukemia.
Hu D; Zhou W; Wang F; Shu SM; Fan LL; He J; Wang P; He YL; Du W; Zhang JH; Duan JX; Sun L; Zheng J; Li XQ; Li HY; Feng XL; Huang SA
Int J Lab Hematol; 2016 Dec; 38(6):663-673. PubMed ID: 27460049
[TBL] [Abstract][Full Text] [Related]
4. Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question.
Jaramillo S; Schlenk RF
Haematologica; 2023 Feb; 108(2):342-352. PubMed ID: 36722404
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
6. The transcriptomic landscape of elderly acute myeloid leukemia identifies
Villar S; Ariceta B; Agirre X; Urribarri AD; Ayala R; Martínez-Cuadrón D; Bergua JM; Vives S; Algarra L; Tormo M; Martínez P; Serrano J; Simoes C; Herrera P; Calasanz MJ; Alfonso-Piérola A; Paiva B; Martínez-López J; San Miguel JF; Prósper F; Montesinos P
Front Oncol; 2022; 12():1054458. PubMed ID: 36505804
[TBL] [Abstract][Full Text] [Related]
7. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
8. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells.
Goyama S; Schibler J; Cunningham L; Zhang Y; Rao Y; Nishimoto N; Nakagawa M; Olsson A; Wunderlich M; Link KA; Mizukawa B; Grimes HL; Kurokawa M; Liu PP; Huang G; Mulloy JC
J Clin Invest; 2013 Sep; 123(9):3876-88. PubMed ID: 23979164
[TBL] [Abstract][Full Text] [Related]
10. Regulation of c-fos gene transcription and myeloid cell differentiation by acute myeloid leukemia 1 and acute myeloid leukemia-MTG8, a chimeric leukemogenic derivative of acute myeloid leukemia 1.
Hwang ES; Hong JH; Bae SC; Ito Y; Lee SK
FEBS Lett; 1999 Mar; 446(1):86-90. PubMed ID: 10100620
[TBL] [Abstract][Full Text] [Related]
11. Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report.
Cheng J; Liao Y; Bin T; OUYang J; Chen S; Chen X; Zou W
Curr Med Res Opin; 2020 Nov; 36(11):1807-1812. PubMed ID: 32936052
[TBL] [Abstract][Full Text] [Related]
12. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
[TBL] [Abstract][Full Text] [Related]
13. Biomolecular Condensates in Myeloid Leukemia: What Do They Tell Us?
Jevtic Z; Allram M; Grebien F; Schwaller J
Hemasphere; 2023 Jul; 7(7):e923. PubMed ID: 37388925
[TBL] [Abstract][Full Text] [Related]
14. Molecular landscape in acute myeloid leukemia: where do we stand in 2016.
Al-Issa K; Nazha A
Cancer Biol Med; 2016 Dec; 13(4):474-482. PubMed ID: 28154779
[TBL] [Abstract][Full Text] [Related]
15. IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia.
Aubrey BJ; Cutler JA; Bourgeois W; Donovan KA; Gu S; Hatton C; Perlee S; Perner F; Rahnamoun H; Theall ACP; Henrich JA; Zhu Q; Nowak RP; Kim YJ; Parvin S; Cremer A; Olsen SN; Eleuteri NA; Pikman Y; McGeehan GM; Stegmaier K; Letai A; Fischer ES; Liu XS; Armstrong SA
Nat Cancer; 2022 May; 3(5):595-613. PubMed ID: 35534777
[TBL] [Abstract][Full Text] [Related]
16. SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia.
Cristóbal I; Blanco FJ; Garcia-Orti L; Marcotegui N; Vicente C; Rifon J; Novo FJ; Bandres E; Calasanz MJ; Bernabeu C; Odero MD
Blood; 2010 Jan; 115(3):615-25. PubMed ID: 19965692
[TBL] [Abstract][Full Text] [Related]
17. The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia.
Rashidi A; Wolach O; El-Jawahri A; Ho VT; DiPersio JF; Soiffer R; Stone RM; Chen YB
Leuk Lymphoma; 2016 Aug; 57(8):1977-9. PubMed ID: 27003236
[No Abstract] [Full Text] [Related]
18. Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes.
Dharmani C; Wang E; Tu N; Fofah O; Cueto J; Salas M; Kamel YM
Future Oncol; 2023 Aug; 19(24):1677-1693. PubMed ID: 37345543
[TBL] [Abstract][Full Text] [Related]
19. New agents in acute myeloid leukemia (AML).
Park S; Cho BS; Kim HJ
Blood Res; 2020 Jul; 55(S1):S14-S18. PubMed ID: 32719171
[TBL] [Abstract][Full Text] [Related]
20. The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia - Response to Rashidi et al.
McGregor AK; Moulton D; Bown N; Cuthbert G; Bourn D; Mathew S; Dang R; Mounter P; Jones G
Leuk Lymphoma; 2016 Aug; 57(8):1980-1. PubMed ID: 27090743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
